The Disruptive Nature of Personalized Medicine Technologies: Implications for the Health Care System
The Disruptive Nature of Personalized Medicine Technologies: Implications for the Health Care System
复制标题
DOI：
10.1159/000189631
复制
发表时间：
2009-01-01
影响因子：
1.7
通讯作者：
Carlson, R. J.
中科院分区：
文献类型：
--
作者：
Carlson, R. J.
基因组学技术，尽管复杂性和低生产力，迄今为止，一旦转化为临床护理，通过具有成本效益的干预和预防，有望显着改善成果。但是，沿着，每一个商业模式和每一个利益相关者群体都将面临挑战，以适应我们的医疗保健系统寻求拥抱这些技术时将出现的中断。本文确定了许多直接影响的关键问题和利益相关者，包括付款人，提供商和供应商。如果要优化这些技术，公共政策制定者将面临更大的挑战。其中许多问题也被提出。最后，最大的障碍并不一定是由利益相关者提出的，而是来自科学本身的复杂性不断加深，需要公共和私营部门的长期，大规模和一致的研究承诺，这是一个不可否认的承诺，需要改革目前的医疗保健系统。版权所有（C）2009 S. Karger AG，巴塞尔
Genomics technologies, notwithstanding rising complexity and low productivity to date, once translated to clinical care, promise significantly improved outcomes through cost-effective interventions and prevention. But, along the way, every business model and every stakeholder group will be challenged to adapt to the disruptions that will arise as our health care system seeks to embrace those technologies. This paper identifies many of the key issues and stakeholders to be directly effected, including payers, providers, and suppliers. An even greater challenge faces public policy makers if these technologies are to be optimized. Many of these issues are raised as well. Finally, the point is made that the greatest barriers are not necessarily raised by stakeholders but rather arise from the deepening complexity of the science itself, requiring a long-term, large, and consistent research commitment from both the public and private sectors a commitment made harder by the indisputable need to reform the current health care system. Copyright (C) 2009 S. Karger AG, Basel